Overview
What is Stem Cell Cancer And Regenerative Medicine Research Inc?
Stem Cell Cancer and Regenerative Medicine Research Inc, based in Boynton Beach, Florida, is a nonprofit organization dedicated to scientific and educational pursuits. Their primary focus is conducting research to uncover the molecular basis of cancer and degenerative diseases, with a particular emphasis on multiple myeloma. In May 2008, they collaborated with scientists at Wake Forest University to develop a protocol for using granulocytes to treat solid tumors. After obtaining necessary approvals, they initiated a phase I/II clinical trial for 29 patients. As of 2022, 17 patients have been treated, and over 260 donors have been evaluated. The organization operates with a commitment to advancing knowledge in the field of cancer and regenerative medicine.
What are the reviews and ratings of this charity?
Charity Navigator Rating: 94%, Four-Star out of Four Star rating.
Stem Cell Cancer And Regenerative Medicine Research Inc has demonstrated a strong commitment to accountability and transparency, reflected in its high score of 94%. The organization boasts an independent board, with 57% of its members being independent, and has implemented robust policies for conflict of interest, whistleblowing, and document retention. Their financial health is solid, featuring a low liabilities to assets ratio of 0.68% and a program expense ratio of 89.08%, indicating that a significant portion of their funds are directed towards their mission-driven programs.
The charity's financial practices appear sound, with no material diversion of assets reported. This indicates a responsible management of resources, ensuring that funds are used effectively to further their goals in cancer and regenerative medicine research. The presence of documented board meeting minutes also suggests a level of transparency and governance that is commendable.
While the organization has shown many strengths, ongoing monitoring of their financial practices and program effectiveness will be essential to maintain this level of performance. Overall, Stem Cell Cancer And Regenerative Medicine Research Inc stands out as a reliable nonprofit dedicated to impactful research, with a structure that supports its mission.
This AI summary has been generated from information found on Charity Navigator.
Is Stem Cell Cancer And Regenerative Medicine Research Inc legitimate?
Stem Cell Cancer And Regenerative Medicine Research Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Stem Cell Cancer And Regenerative Medicine Research Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
What is the mission statement of Stem Cell Cancer And Regenerative Medicine Research Inc?
Stem Cell Cancer and Regenerative Medicine Research Inc is dedicated to conducting scientific and educational research with a focus on uncovering the molecular basis of cancer and degenerative diseases, particularly multiple myeloma and other chronic conditions. The organization's mission is to explore the potential of stem cells in treating these diseases, including solid tumors. In 2008, they initiated a collaboration with scientists at Wake Forest University to develop a protocol using granulocytes for treating solid tumors. This protocol was subsequently modified, and investigational new drug approval was obtained for a phase I/II clinical trial involving 29 patients. By 2022, the organization had treated 17 patients and evaluated 260 potential donors.
What is the revenue of Stem Cell Cancer And Regenerative Medicine Research Inc?
Stem Cell Cancer And Regenerative Medicine Research Inc's revenue in 2023 was $14,514.
Who are the executives of Stem Cell Cancer And Regenerative Medicine Research Inc and what are their salaries?
Here are 8 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Where can I find the form 990 for Stem Cell Cancer And Regenerative Medicine Research Inc?
Stem Cell Cancer And Regenerative Medicine Research Inc's most recent form 990 was submitted in 2023 and can be accessed here.
Mission Statement of Stem Cell Cancer And Regenerative Medicine Research Inc
Stem Cell Cancer and Regenerative Medicine Research Inc, for short, is dedicated to conducting research with a primary focus on uncovering the molecular mechanisms underlying cancer and degenerative diseases. The organization has a particular emphasis on multiple myeloma and other chronic diseases, including frailty. Their mission is to delve into the intricacies of these conditions, with the ultimate goal of identifying potential treatments and cures.
In May 2008, Stem Cell Cancer and Regenerative Medicine Research Inc began a collaboration with scientists at Wake Forest University. This partnership led to the development of a protocol for utilizing granulocytes to treat solid tumors. The protocol was subsequently modified and in October 2008, investigational new drug approval was granted for a phase I/II clinical trial involving 29 patients. Western Institutional Review Board approval followed in November 2008. As of 2022, the organization has treated 17 patients using this method and has evaluated over 260 potential donors.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
August, 2024
Stem Cell Cancer And Regenerative Medicine Research Inc has made a significant impact in the field of medical research, specifically in the investigation of the molecular basis of cancer and degenerative diseases, with a focus on multiple myeloma. The organization has collaborated with scientists at Wake Forest University to develop a protocol using granulocytes for treating solid tumors. This groundbreaking research led to the implementation of a Phase I/II clinical trial for 29 patients, with investigational new drug approval obtained in 2008.
Since then, Stem Cell Cancer And Regenerative Medicine Research Inc has continued to advance its mission, treating a total of 17 patients and evaluating 260 donors by 2022. This research has the potential to significantly impact the field of oncology and degenerative diseases, offering new insights and potential treatment options for patients facing these challenging conditions.
This information is meant to be a general summary of Stem Cell Cancer And Regenerative Medicine Research Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2023.
- Investment Income: $4,320
- Gross Receipts: $14,514
Assets and Liabilities:
- Total Assets: $580,762
- Total Liabilities: $3,970
- Net Assets: $576,792
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2007
Principal Officer
Dipnarine Maharaj Md
NTEE Category
Code: H90 - Medical research
If you are a representative of Stem Cell Cancer And Regenerative Medicine Research Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.